Literature DB >> 23261233

A review of evidence for safe abortion care.

Nathalie Kapp1, Patti Whyte, Jennifer Tang, Emily Jackson, Dalia Brahmi.   

Abstract

BACKGROUND: The provision of safe abortion services to women who need them has the potential to drastically reduce or eliminate maternal deaths due to unsafe abortion. The World Health Organization recently updated its evidence-based guidance for safe and effective clinical practices using data from systematic reviews of the literature.
MATERIALS AND METHODS: Systematic reviews pertaining to the evidence for safe abortion services, from pre-abortion care, medical and surgical methods of abortion and post-abortion care were evaluated for relevant outcomes, primarily those relating to safety, effectiveness and women's preference.
RESULTS: Sixteen systematic reviews were identified and evaluated. The available evidence does not support the use of pre-abortion ultrasound to increase safety. Routine use of cervical preparation with osmotic dilators, mifepristone or misoprostol after 14 weeks gestation reduces complications; at early gestational ages, surgical abortions have very few complications. Prophylactic antibiotics result in lower rates of post-surgical abortion infection. Pain medication such as non-steroidal anti-inflammatories should be offered to women undergoing abortion procedures; acetaminophen, however, is not effective in reducing pain. Women who are eligible should be offered a choice between surgical (vacuum aspiration or dilation and evacuation) and medical methods (mifepristone and misoprostol) of abortion when possible. Modern methods of contraception can be safely initiated immediately following abortion procedures.
CONCLUSIONS: Evidence-based guidelines assist health care providers and policymakers to utilize the best data available to provide safe abortion care and prevent the millions of deaths and disabilities that result from unsafe abortion.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abortion care; Evidence-based guidelines; Medical abortion; Surgical abortion

Mesh:

Substances:

Year:  2012        PMID: 23261233     DOI: 10.1016/j.contraception.2012.10.027

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

1.  Usual hospital care versus post-abortion care for women with unsafe abortion: a case control study from Sri Lanka.

Authors:  Carukshi Arambepola; Lalini C Rajapaksa; Chandani Galwaduge
Journal:  BMC Health Serv Res       Date:  2014-10-31       Impact factor: 2.655

Review 2.  Oral contraception following abortion: A systematic review and meta-analysis.

Authors:  Yan Che; Xiaoting Liu; Bin Zhang; Linan Cheng
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy.

Authors:  Adrienn Lajko; Matyas Meggyes; Beata Polgar; Laszlo Szereday
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

4.  Moving from legality to reality: how medical abortion methods were introduced with implementation science in Zambia.

Authors:  Tamara Fetters; Ghazaleh Samandari; Patrick Djemo; Bellington Vwallika; Stephen Mupeta
Journal:  Reprod Health       Date:  2017-02-16       Impact factor: 3.223

5.  Abortion-related care and the role of the midwife: a global perspective.

Authors:  Judith Fullerton; Michelle M Butler; Cheryl Aman; Tobi Reid; Melanie Dowler
Journal:  Int J Womens Health       Date:  2018-11-23

6.  Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.

Authors:  Wendy V Norman; Sarah Munro; Melissa Brooks; Courtney Devane; Edith Guilbert; Regina Renner; Tamil Kendall; Judith A Soon; Ashley Waddington; Marie-Soleil Wagner; Sheila Dunn
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

7.  COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING.

Authors:  Zahra Dehbashi; Mahmood Moosazadeh; Mahdi Afshari
Journal:  Mater Sociomed       Date:  2016-07-24

8.  The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss.

Authors:  Li Sun; Zhengwei Yuan; Lingyan Jian; Qinghua Jiang; Siwen Zhang; Jichun Tan
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-16       Impact factor: 2.629

9.  A Retrospective Cost-Effectiveness Analysis of Mifepristone-Misoprostol Medical Abortions in the First Year at the Regina General Hospital.

Authors:  Caitlin Hunter; Joshua Jensen; Biaka Imeah; Michelle McCarron; Megan Clark
Journal:  J Obstet Gynaecol Can       Date:  2020-08-25

10.  Medical abortion at 13 or more weeks gestation provided through telemedicine: A retrospective review of services.

Authors:  Nathalie Kapp; Kathryn Andersen; Risa Griffin; Amalia Puri Handayani; Marlies Schellekens; Rebecca Gomperts
Journal:  Contracept X       Date:  2021-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.